AzTrials
AzTrials

StressNCT06200792

Stress and Anxiety Affect Residents' Performance

An observational study of Stress and Stress Disorder, run by University of Padova at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Being an anesthesiologist implies huge dedication and both physical and psychological efforts. None has ever studied the impact of a working day on anxiety, perceived stress levels, physiological data, and executive functions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stress, Stress Disorder, Work Related Stress
What is being tested?
eSense device
Type of treatment
Medical device
How many people
40 participants
Where
1 siteItaly
Study dates
1 Jan 2024to 1 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Anesthesiologists residents

Who may be able to join

  • Being an anesthesiologist residents
  • Written informed consent obtained

Who cannot join

  • Psychiatric disorders
  • Neurological disorders
  • Suffering from high blood pressure

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Clinica Odontoiatrica

    Padova, 35126

Other trials in Italy

About this study

Official title: The Impact of Stress in Residents' Performance

Being an anesthesiologist implies huge dedication and both physical and psychological efforts. None has ever studied the impact of a working day on anxiety, perceived stress levels, physiological data, and executive functions.

Read the detailed description

During a working day, trainees will have their physiological and psychological data recorded before starting their clinical activity and after them. Electrodermal activity with the eSense device, Executive functions through the TOL-R and all the questionnaires and scales will be sampled at the beginning of the day and at the end of the day the same procedure will be applied again (exclusion for PSS-10 scale, STAY-Y trait anxiety and GAD-7) eSense and TOL-R, are useful tools to understand sympathetic activity and executive functions. The galvanometer it is the gold standard to measure EDA; i.e. electrodermal activity, which is a pure sympathetic index, while Tower of London it is the gold standard to assess planning, monitoring and programming skills, both data are supposed to be heavily involved in an anesthesiologist trainee during the all day.

The aims of the study are to evaluate executive functions at the start and at the end of a working day and to understand theirs relationship with anxiety, perceived stress levels and physiological changes in sympathetic activity.

Being tested
eSense device
Medical subject headings
Stress Disorders, Traumatic, Occupational Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • eSense deviceDevice

    Also called Questionnaires and scales for evaluating esecutive function.

    eSense device for monitoring electrodermal activity. Visual analogic scale (VAS) for pain and discomfort; TOL-R tests for investigating working performances.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in executive functions overtime

    Evaluating executive functions at the start and at the end of a working day using the Tower of London test (TOL-R) (scoring 0 (worst score)-30 (better score))

    Measured: baseline and immediately after intervention

Secondary outcomes (4)
  1. Differences in dermal activity during working day

    Evaluating potential differences in electrodermal activity overtime using microsiemens, counting number of stress response

    Measured: baseline and immediately after intervention

  2. Assess the general level of anxiety

    Measuring levels of anxiety using the generalized anxiety disorder-7 item (GAD-7) (minimum 0, maximum score 21)

    Measured: baseline and immediately after intervention

  3. General level of anxiety

    Measuring the general levels of anxiety with the Stait-trait anxiety inventory (STAI-Y1-2) (1 point=not at all/almost never anxiety; 2=somewhat/sometimes; 3=moderately so/often) and 4= very much so/almost always)

    Measured: baseline and immediately after intervention

  4. Evaluating the general levels of perceived stress levels

    Evaluation of the general levels of perceived stress levels using the perceived stress score (PSS)-10 scale (0 (minimum level of anxiety)-10 (maximum level of anxiety))

    Measured: baseline and immediately after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2024
  2. Study start1 Jan 2024
  3. Primary completion1 Mar 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06200792
Sponsor's protocol ID
Stress study
Status last verified
Dec 2024
First submitted
7 Dec 2023
Last updated
31 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Nope

Questions about this trial

What is this clinical trial studying?

An observational study of Stress and Stress Disorder, run by University of Padova at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in executive functions overtime (time frame: baseline and immediately after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in